000 01288 a2200373 4500
005 20250517145026.0
264 0 _c20170814
008 201708s 0 0 eng d
022 _a1466-1861
024 7 _a10.1155/2017/3708250
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDénarié, Delphine
245 0 0 _aMethotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab.
_h[electronic resource]
260 _bMediators of inflammation
_c2017
300 _a3708250 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aBiological Assay
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfliximab
_xtherapeutic use
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aRinaudo-Gaujous, Mélanie
700 1 _aThomas, Thierry
700 1 _aPaul, Stéphane
700 1 _aMarotte, Hubert
773 0 _tMediators of inflammation
_gvol. 2017
_gp. 3708250
856 4 0 _uhttps://doi.org/10.1155/2017/3708250
_zAvailable from publisher's website
999 _c27024963
_d27024963